iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 126.77 billion as of September 19, 2025. Its market cap has decreased by -40.57% in one year.

Market Cap

126.77B

Enterprise Value

86.44B

Revenue

5.14B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,010.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 126.77B, an increase of 33.03%. That is a compound annual growth rate of 1.97%.

Market Cap History

Date	Market Cap	% Change
Sep 19, 2025	126.77B	-30.94%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	915.06B	97.15%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.88T
Celltrion	37.63T
ALTEOGEN	25.25T
SK Biopharmaceuticals	8,888.55B
Yuhan	8,872.07B
Peptron	6,750.37B
PharmaResearch	6,202.62B
ABL Bio	5,910.48B

Market Cap Rankings